Join our Stock Market News Group at GetPaidIndia on Telegram and WhatsApp.

This website is purely ACADEMIC in nature and NOT a stock market recommendation service or a tip provider. No live data or feeds are provided and all information is historic only. Information is provided for ease of understanding for the purpose of learning. Accuracy of definitions etc is not mantained. I am not a SEBI or IRDA registered.

Glenmark Pharmaceuticals Limited



From GetPaidIndia.com
Jump to:navigation, search

In The News

GBR 830 is an Investigational, First-in-Class, Anti-OX40 Monoclonal Antibody

Market Capitalization

  • December 27, 2017: Rs. 16487 Cr (Mid Cap)

Related Lesson: Why is Market Capitalization and stock liquidity important for the investor?

Markets Mojo

Date Quality Valuation Financial Trend
December 27, 2017 Excellent (Rank # 4 of 170 ) Very Attractive Negative (Score: -8 )

Related Lessons: Learn what are Qualitative and Quantitative factors, CMP and Stock valuation and Financial Trend Analysis

MarketSmithIndia Score

Date Master Score EPS Strength Price Strength Buyer Demand Group Rank
Decemebr 27, 2017 C Fair: 78 Poor: 12 Good: B Poor: 123

Companies with MarketSmithIndia Score of A or B are usually good.

Stock Axis Rating and Ranking

Date Rating Ranking
October 3, 2017 2 / 5 33 / 99
August 24, 2017 2 / 5 34 / 99

Technical Indicators

Date Present Super Trend Trend Reversal PSAR Williams %R (14) CCI (20) ADX (14)
December 27, 2017 Bullish 525.82 Bullish -12.50 Overbought (Bearish) +144 Strong Uptrend (Bullish) 28.20 (Neutral)
October 6, 2017 Sell 613.92 Sell -17.13 Overbought (Sell) +153 Strong Uptrend (Buy) 32.82 (Neutral)
October 3, 2017 Bearish 633.31 Bearish -65.57 (Neutral) -17 (Neutral) 20.71 (Neutral)
September 13, 2017 Bearish 590.49 Bullish -65.52 (Neutral) -92 (Neutral) 36.93 (Neutral)
September 1, 2017 Bearish 671.69 Bearish -62.53 (Neutral) -48 (Neutral) 35.11 (Neutral)
August 24, 2017 Bearish 676.53 Bearish -82.25 Oversold (Bullish) -72 Strong Downtrend (Bearish) 39.72 Strong Trend (Bullish)
May 24, 2017 Bearish 797.21 Bearish -95.78 Oversold (Bullish) -123 Strong Downtrend (Bearish) 41.12 Strong Trend (Bullish)
May 19, 2017 Bearish 868.16 Bearish -95.30 Oversold (Bullish) -198 Strong Downtrend (Bearish) 32.75 (Neutral)
May 15, 2017 Bearish 918.55 Bearish -84.88 Oversold (Bullish) -307 Strong Downtrend (Bearish) 25.68 (Neutral)

Chart Frequency: 1 Day; Chart Style: Heikin Ashi

SuperTrend Parameters: Period: 7; Multiplier: 3

Parabolic SAR: Minimum AF: 0.02; Maximum AF: 0.2

Coverage / Ratings / Rankings

Date Source Category Ranking / Description
October 10, 2017 Reliance Securities Diwali Picks Buy Reco Price: 611; Target: 900
October 2017 Edelweiss Style Analysis Portfolio October 2017 Mentioned in Top 10 Long-Portfolio stocks
August 14, 2017 Geojit BNP Paribas Buy Target of Rs 647
July 24 - 30, 2017 Money Times Tower Talk If reports are true, Glenmark Pharmaceuticals is expected to get a milestone payment for one of its mole. A good buy at the current beaten down share price.

Financial Results

Historical Data

Related / Peer Companies

Related Categories

External Links